Mirador Therapeutics
Biotechnology company focused on developing precision medicines for immune-related diseases, leveraging advanced biology and data science to identify and target disease mechanisms.
Website
https://www.miradortx.comLocation
San Diego, California, USA
Founded
2023
Investors
3
Categories
therapeutics, biotech, precision-medicine, immunology, inflammatory-disease
Notes
Mirador Therapeutics is a biotechnology company focused on developing precision medicines for immune-related diseases, including inflammatory bowel disease and other immune-mediated conditions. The company emerged with one of the largest early-stage funding rounds in biotech history, reflecting investor confidence in its precision approach to immunology.
Mirador leverages advanced biology, data science, and deep disease understanding to identify novel therapeutic targets and develop drugs that precisely address the underlying causes of immune dysfunction.
Team
- Jörn Drappa, M.D., Ph.D. - Chief Executive Officer
- LinkedIn: linkedin.com/in/jorn-drappa
Additional Research Findings
- Founded in 2023
- Headquarters in San Diego, California
- Raised over $400 million in early funding rounds (March 2024)
- Led by ARCH Venture Partners
- Investors include OrbiMed and Sanofi Ventures
- Precision medicine approach for immune diseases
- Focus on inflammatory bowel disease
- One of largest early-stage biotech funding rounds
Sources
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| ARCH Venture Partners | Chicago, USA | biotech-focused | seedseries-a+3 | 6 |
| OrbiMed | New York, New York, USA | biotech-focused | seedseries-a+3 | 1 |
| Sanofi Ventures | Cambridge, Massachusetts, USA | cvc | seedseries-a+3 | 1 |